Page last updated: 2024-08-16

canrenoic acid and Hyperaldosteronism

canrenoic acid has been researched along with Hyperaldosteronism in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-199015 (78.95)18.7374
1990's0 (0.00)18.2507
2000's4 (21.05)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albiger, N; Armanini, D; Fiore, C; Mattarello, MJ; Sartorato, P; Scaroni, C1
Armanini, D; Fiore, C; Pellati, D1
Jacobelli, A1
Denis, B; Dimitriou, R; Machecourt, J; Page, E; Reboud, JP; Wolf, JE1
Kuntz, E1
Haschke, F; Parth, K; Wimmer, M1
Hirose, H; Kawashima, Y; Matsuda, H; Nakano, S; Nomura, H; Ohtani, M; Shirakura, R; Taniguti, H1
Brazzarola, P; Degan, M; Delva, P; Lechi, A; Montesi, G; Pastori, C1
Ogawa, R; Watanabe, T1
Corvol, P; Freifeld, M; Mahoudeau, J; Menard, J; Michaud, A1
Chisaka, E; Fukuma, M; Imamura, T; Kashiwagi, S; Sasaki, J1
Claire, M; Corvol, P; Menard, J; Michaud, A; Rafestin-Oblin, ME; Roth-Meyer, C1
Ambrosioni, E; Magnani, B; Pasetti, L; Tartagni, F1
Bräuninger, HJ; Gorbach, HC1
Ciaccio, S; Coltorti, M; Corsini, R; Radaeli, E; Trebbi, R1
Ambrosioni, E; Tartagni, F1
Dupont, A1
Cuppone, R; Emili, M; Ricci, GL1
Kiyose, H; Nagano, M; Tagawa, H; Tanaka, S; Umezu, M; Yamakado, M1

Reviews

1 review(s) available for canrenoic acid and Hyperaldosteronism

ArticleYear
Spirolactones: clinical and pharmacologic studies.
    Advances in nephrology from the Necker Hospital, 1977, Volume: 7

    Topics: Aldosterone; Animals; Binding, Competitive; Canrenoic Acid; Canrenone; Diuresis; Humans; Hyperaldosteronism; Hypertension; In Vitro Techniques; Kidney; Mineralocorticoid Receptor Antagonists; Pregnadienes; Protein Binding; Rats; Receptors, Cell Surface; Spironolactone

1977

Trials

4 trial(s) available for canrenoic acid and Hyperaldosteronism

ArticleYear
Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate.
    Journal of endocrinological investigation, 2005, Volume: 28, Issue:3

    Topics: Adult; Aldosterone; Blood Pressure; Canrenoic Acid; Electrolytes; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System

2005
[Hyperaldosteronism in the acute phase of myocardial infarction. Effects of its treatment on the prevention of ventricular fibrillation].
    Archives des maladies du coeur et des vaisseaux, 1984, Volume: 77 Spec No

    Topics: Acute Disease; Adult; Aged; Anti-Arrhythmia Agents; Canrenoic Acid; Clinical Trials as Topic; Female; Heparin; Humans; Hyperaldosteronism; Male; Middle Aged; Myocardial Infarction; Pregnadienes; Spironolactone; Ventricular Fibrillation

1984
Suppression of surgical hyperaldosteronism by potassium canrenoate during gynecologic surgery under sevoflurane anesthesia.
    Acta anaesthesiologica Scandinavica, 2000, Volume: 44, Issue:6

    Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Anesthesia, Inhalation; Anesthetics, Inhalation; Blood Pressure; Canrenoic Acid; Female; Gynecologic Surgical Procedures; Humans; Hyperaldosteronism; Intraoperative Complications; Male; Methyl Ethers; Mineralocorticoid Receptor Antagonists; Potassium; Renin; Sevoflurane; Sodium

2000
Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
    Arzneimittel-Forschung, 1988, Volume: 38, Issue:10

    Topics: Aldosterone; Canrenoic Acid; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyperaldosteronism; Liver Cirrhosis; Liver Function Tests; Male; Pregnadienes; Random Allocation; Spironolactone

1988

Other Studies

14 other study(ies) available for canrenoic acid and Hyperaldosteronism

ArticleYear
Spontaneous resolution of idiopathic aldosteronism after long-term treatment with potassium canrenoate.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:4

    Topics: Aged; Canrenoic Acid; Dose-Response Relationship, Drug; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Remission, Spontaneous; Time Factors; Treatment Outcome

2007
[Treatment of hyperaldosteronism].
    La Clinica terapeutica, 1984, Jun-30, Volume: 109, Issue:6

    Topics: Adrenal Cortex Diseases; Canrenoic Acid; Female; Humans; Hyperaldosteronism; Male; Spironolactone

1984
[Disorders of water and electrolyte equilibrium in liver diseases. Part 3: therapy (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1982, May-14, Volume: 124, Issue:19

    Topics: Ascites; Benzothiadiazines; Canrenoic Acid; Diuretics; Humans; Hyperaldosteronism; Liver Diseases; Sodium Chloride Symporter Inhibitors; Spironolactone; Water-Electrolyte Imbalance

1982
Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists.
    Padiatrie und Padologie, 1981, Volume: 16, Issue:3

    Topics: Adolescent; Aldosterone; Canrenoic Acid; Child; Child, Preschool; Heart Defects, Congenital; Hematocrit; Humans; Hyperaldosteronism; Infant; Mineralocorticoid Receptor Antagonists; Postoperative Complications; Potassium; Sodium; Spironolactone

1981
[Preventive measures against postoperative secondary aldosteronism following open heart surgery--planned administration of injective aldosterone antagonist].
    Rinsho kyobu geka = Japanese annals of thoracic surgery, 1987, Volume: 7, Issue:1

    Topics: Adult; Aged; Canrenoic Acid; Cardiac Surgical Procedures; Drug Administration Schedule; Female; Humans; Hyperaldosteronism; Hyperkalemia; Injections, Intravenous; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Postoperative Complications; Premedication; Preoperative Care

1987
Intralymphocyte free magnesium in patients with primary aldosteronism: aldosterone and lymphocyte magnesium homeostasis.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 1

    Topics: Adult; Aldosterone; Antiporters; Calcium; Canrenoic Acid; Case-Control Studies; Female; Homeostasis; Humans; Hyperaldosteronism; In Vitro Techniques; Lymphocytes; Magnesium; Magnesium Deficiency; Male; Middle Aged; Mineralocorticoid Receptor Antagonists

2000
Antiandrogenic effect of spirolactones: mechanism of action.
    Endocrinology, 1975, Volume: 97, Issue:1

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Animals; Binding, Competitive; Canrenoic Acid; Cell Nucleus; Cyproterone; Cytosol; Dihydrotestosterone; Hyperaldosteronism; Hypertension; Male; Prostate; Rats; Receptors, Cell Surface; Spironolactone; Tritium

1975
[A case of primary aldosteronism associated with spironolactone inclusions (author's transl)].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1975, Jun-10, Volume: 64, Issue:6

    Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Canrenoic Acid; Female; Humans; Hyperaldosteronism; Inclusion Bodies; Paranoid Disorders; Spironolactone

1975
[Effectiveness of K canrenoate in the treatment of secondary hyperaldosteronism].
    Giornale di clinica medica, 1979, Volume: 60, Issue:3

    Topics: Canrenoic Acid; Drug Evaluation; Humans; Hyperaldosteronism; Pregnadienes

1979
[Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1975, Volume: 117, Issue:37

    Topics: Administration, Oral; Aged; Blood Pressure; Body Weight; Canrenoic Acid; Female; Heart Failure; Humans; Hyperaldosteronism; Injections; Liver Cirrhosis; Male; Natriuresis; Potassium; Pregnadienes; Sodium; Spironolactone

1975
[Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
    La Clinica terapeutica, 1976, Feb-15, Volume: 76, Issue:3

    Topics: Adult; Aged; Ascites; Canrenoic Acid; Drug Evaluation; Drug Therapy, Combination; Edema; Ethacrynic Acid; Female; Furosemide; Heart Failure; Humans; Hyperaldosteronism; Liver Cirrhosis; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Pregnadienes; Water-Electrolyte Imbalance

1976
[The use of an injectable anti-aldosteron agent in the treatment of secondary hyperaldosteronism].
    Bollettino della Societa italiana di cardiologia, 1976, Volume: 21, Issue:4

    Topics: Adult; Aged; Canrenoic Acid; Drug Evaluation; Female; Humans; Hyperaldosteronism; Injections, Intravenous; Male; Middle Aged; Pregnadienes

1976
Disappearance of spironolactone-induced gynaecomastia during treatment with potassium canrenoate.
    Lancet (London, England), 1985, Sep-28, Volume: 2, Issue:8457

    Topics: Canrenoic Acid; Gynecomastia; Humans; Hyperaldosteronism; Male; Middle Aged; Pregnadienes; Spironolactone

1985
Extrarenal role of aldosterone in the regulation of blood pressure.
    American journal of hypertension, 1988, Volume: 1, Issue:3 Pt 1

    Topics: Adult; Aged; Aldosterone; Blood Pressure; Canrenoic Acid; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension, Renovascular; Kidney; Middle Aged; Vascular Resistance; Vasoconstriction

1988